rabeprazole has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosokawa, K; Inohara, H; Iwahashi, T; Ogawa, M | 1 |
1 other study(ies) available for rabeprazole and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
The results of Kaplan-Meier and multivariate analyses of etiological factors related to the outcome of combined pharmacological therapy against laryngeal granuloma.
Topics: Adult; Aged; Anti-Allergic Agents; Beclomethasone; Drug Therapy, Combination; Female; Glucocorticoids; Granuloma, Laryngeal; Humans; Kaplan-Meier Estimate; Male; Middle Aged; ortho-Aminobenzoates; Proportional Hazards Models; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2016 |